SMi is delighted to announce its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 13th-14th May 2019.
The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.
The event will explore current market trends, challenges of correctly assessing hazard, the use of innovative containment solutions to minimize risk and advanced manufacturing processes. In addition, the conference aims to guide attendees through novel regulatory updates for each stage of HPAPI development.
Attend this conference and join our networking platform for industry professionals to provide you with the expertise to overcome the challenges of the HPAPI industry.
How Will You Benefit?
Network and learn from leading professionals such as:
CHAIR FOR 2019 – Justin Mason-Home, Director, HPAPI ProjectServices Limited
KEY SPEAKERS INCLUDE:
View the full agenda: www.highlypotentapi.com/world
Social Media Handles
Additional Contact Info:
T: +44 (0) 20 7827 6164
© 2018 PHARMA NEWS HQ, All rights reserved
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.